Can You Have High Testosterone and High Estrogen?

Yes, you can absolutely have high testosterone and high estrogen at the same time. In fact, the two hormones are biochemically linked: your body converts testosterone into estrogen through an enzyme called aromatase, so higher testosterone levels often drive estrogen levels up as well. This is one of the most common hormonal imbalances seen in men on testosterone therapy, but it also occurs naturally in both men and women under certain conditions.

How Testosterone Becomes Estrogen

Testosterone and estrogen aren’t independent systems. Your body uses an enzyme called aromatase to convert testosterone (and other androgens) into estrogen through a series of chemical reactions. This conversion happens in several tissues throughout the body, but fat tissue is one of the most active sites. The more testosterone circulating in your system, the more raw material aromatase has to work with, which means more estrogen gets produced as a byproduct.

This is why simply having high testosterone can push estrogen levels higher. The process is automatic. Your body doesn’t ask permission before converting one hormone into another. And certain factors can make aromatase work even harder. Estrogen itself, through a feedback loop, can actually increase aromatase activity, meaning elevated estrogen promotes even more of its own production. Growth factor signaling pathways in the body can amplify this effect further.

Body Fat Is a Major Driver

Fat tissue plays an outsized role in this equation. Aromatase is expressed in immature fat cells throughout the body, and a larger volume of fat tissue means more cells actively converting testosterone into estrogen. But it’s not just about having more fat cells. Aromatase expression per unit of fat tissue also increases with weight gain, so each cell becomes more efficient at the conversion as body fat rises.

Obesity also triggers inflammatory signaling molecules like TNF and prostaglandin E2, both of which activate aromatase gene promoters and ramp up production even further. This creates a compounding effect: more body fat leads to more estrogen production, which can promote additional fat storage, which then increases aromatase activity. For men carrying significant abdominal fat, this cycle is one of the most common reasons for finding both hormones elevated on bloodwork.

Testosterone Therapy and Estrogen Spikes

Men on testosterone replacement therapy are especially prone to this dual elevation. In a large screening of over 34,000 men treated at testosterone clinics, about 20% had estradiol levels above the clinical threshold of 42.6 pg/mL. That’s roughly one in five men on injectable testosterone developing meaningfully high estrogen. For reference, the normal male estradiol range is 20 to 50 pg/mL, so levels above that upper limit signal a real imbalance.

The mechanism is straightforward. Injectable testosterone delivers a surge of the hormone into your bloodstream. Aromatase in your fat tissue and other organs converts a portion of that testosterone into estradiol. The higher the dose, the more conversion occurs. Men with more body fat, older men, and those on higher injection doses tend to see the most dramatic estrogen increases.

What This Looks Like in Women

Women can also have both hormones elevated simultaneously, though the pattern looks different. Polycystic ovary syndrome (PCOS) is the most common example. PCOS involves a disruption in the hormonal signals from the brain to the ovaries, where luteinizing hormone (LH) rises disproportionately compared to follicle-stimulating hormone (FSH). Normally, FSH is about twice as high as LH. In roughly 83% of women with PCOS, this ratio flips, with LH becoming two or three times higher than FSH.

This hormonal shift drives the ovaries to produce excess androgens, including testosterone. Meanwhile, the increased aromatase activity from body fat (many women with PCOS also carry extra weight) converts some of those androgens into estrogen. The result is elevated levels of both. The diagnostic criteria for PCOS require two of three features: signs of excess androgens, irregular or absent ovulation, and polycystic-appearing ovaries on ultrasound. Normal testosterone for women of reproductive age falls between 15 and 46 ng/dL, and levels above that range alongside elevated estrogen point toward this diagnosis.

Symptoms to Watch For

In men, the symptoms of high estrogen tend to be the ones you notice first, even if testosterone is also elevated. Breast tissue enlargement (gynecomastia) is one of the hallmark signs. Erectile dysfunction and reduced fertility can also occur, which feels counterintuitive when testosterone is high. You might expect high testosterone to boost sexual function, but when estrogen climbs alongside it, the balance between the two matters more than the absolute level of either one.

Water retention, mood swings, and increased emotional sensitivity are other common complaints. Some men report feeling bloated or noticing puffiness in the face and midsection that doesn’t match their diet or activity level.

In women with both hormones elevated, symptoms typically include irregular periods, acne, excess facial or body hair from the testosterone side, combined with breast tenderness and heavier bleeding episodes from the estrogen side. The combination creates a confusing mix of symptoms that can seem contradictory.

Why the Ratio Matters More Than Either Number

Clinicians increasingly focus on the testosterone-to-estradiol ratio rather than looking at each hormone in isolation. This ratio is calculated by dividing testosterone (in ng/dL) by estradiol (in pg/mL). A ratio between 10 and 30 appears to be the beneficial range for men. Higher ratios are associated with better sperm production but potentially reduced bone density. Lower ratios, particularly below 10, are linked to increased cardiovascular mortality risk and erectile dysfunction.

To put this in practical terms: a man with a testosterone level of 800 ng/dL and an estradiol of 50 pg/mL has a ratio of 16, which falls in the healthy range. But if his estradiol climbs to 100 pg/mL, the ratio drops to 8, which enters the danger zone for cardiovascular and sexual health, even though his testosterone looks great on paper. Weight loss can dramatically improve this ratio. One meta-analysis found that men who lost significant weight saw their ratio jump from 7.4 to 24.1, driven by testosterone increasing and estradiol dropping simultaneously.

Cardiovascular and Metabolic Risks

Prolonged estrogen elevation in men carries real metabolic consequences beyond the visible symptoms. Research in cardiovascular diabetology has identified a cluster of metabolic problems that emerge when male bodies are exposed to sustained high estrogen: the liver ramps up glucose production even when insulin signals it to stop, fat cells become enlarged and inflamed rather than multiplying normally, and the body’s ability to clear triglycerides from the blood becomes impaired.

These enlarged fat cells secrete inflammatory signals that attract immune cells called macrophages, which amplify local inflammation and contribute to insulin resistance throughout the body. The liver also produces more VLDL (a type of cholesterol particle) while simultaneously struggling to clear fats from the bloodstream after meals. This combination of insulin resistance, inflammatory fat tissue, and poor lipid clearance creates exactly the metabolic environment that raises heart disease risk. Cardiac imaging in estrogen-exposed males shows modest changes to heart structure, including a larger left ventricular chamber, though pumping function and blood pressure may remain unchanged initially.

How the Imbalance Gets Corrected

The most effective long-term strategy for reducing excess estrogen conversion is lowering body fat. Because fat tissue is the primary site where aromatase converts testosterone to estrogen, losing weight directly reduces the conversion rate. This addresses the root cause rather than just masking the symptoms.

For men on testosterone therapy who develop high estrogen, clinicians sometimes prescribe medications that block aromatase activity. The most commonly used option is prescribed at varying doses depending on the testosterone dose being taken. In a survey of sexual medicine specialists, about 62% used this approach as their first-line treatment for symptomatic high estrogen. Another 24% used a medication that blocks estrogen’s effects at the receptor level rather than reducing production. Dosing varies widely in clinical practice, and getting the balance right often requires repeated bloodwork over several months.

Adjusting the testosterone dose itself, splitting injections into more frequent smaller doses, or switching delivery methods (from injections to topical gels, which produce less dramatic hormone spikes) can also reduce the estrogen surge that comes with each dose.